July saw a significant decrease in biopharmaceutical industry layoffs, with a 94% drop in affected employees compared to the previous year. Only six companies initiated or planned workforce reductions, a 74% decrease in the number of organizations making cuts. Novartis reported the largest single layoff event, impacting 322 individuals. This sharp decline contrasts with July 2025, which saw a much larger workforce reduction due to Merck's extensive cost-cutting initiative. Overall, the biopharma sector experienced a notable slowdown in job cuts last month.
https://www.biospace.com/job-trends/julys-biopharma-layoffs-affect-466-employees-a-94-year-over-year-drop